M
Monod Bio
Biotech & Life Sciences · Seattle, United States · Founded 2021
Develops biosensors intended for protein and other analyte detection MoreLess
Monod Bio is an innovative startup specializing in the design and development of advanced biosensors using cutting-edge protein engineering techniques. Founded in 2021 as a spin-out from the University of Washington Institute for Protein Design, the company leverages the pioneering lucCage technology developed by Dr. David Baker. This technology allows Monod Bio to create highly sensitive and specific biosensors that can detect various biological and chemical substances.
The primary clients of Monod Bio include scientists, healthcare providers, and patients. The company operates in the biotechnology and healthcare markets, focusing on applications that require precise and rapid diagnostic tools. By providing these advanced biosensors, Monod Bio aims to improve the accuracy and efficiency of diagnostic processes, ultimately benefiting patient care and scientific research.
Monod Bio's business model revolves around the development and commercialization of its biosensor technology. The company generates revenue through partnerships with corporate entities interested in integrating these biosensors into their products and services. Additionally, Monod Bio may license its technology to other companies, providing another revenue stream.
The company's biosensor platform is based on de novo protein design, which involves creating new proteins from scratch using computational methods. These proteins act as nanoswitches that can detect specific molecules and trigger a measurable response. This approach allows for the creation of highly modular and customizable biosensors that are both rapid and cost-effective.
Monod Bio's commitment to innovation and excellence is reflected in its diverse and experienced team, which combines scientific expertise with entrepreneurial and business acumen. The company is also dedicated to fostering an inclusive and supportive work environment, valuing the unique perspectives and backgrounds of its employees.
Keywords: biosensors, protein design, biotechnology, healthcare, diagnostics, lucCage technology, nanoswitches, computational engineering, innovation, partnerships.
Company overview
Monod Bio company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2021
- Headquarters
- Seattle, United States
- Employees
- 27
- Open positions
- None listed
- Dealroom signal
- 71.6
Valuation & funding
Monod Bio funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Oct 2025 | $750K | — | Bill & Melinda Gates Foundation | ↗ |
| GRANT✓Other financing | Sep 2025 | $1.5M | — | Bill & Melinda Gates Foundation | ↗ |
| SEED✓Equity / VC | Aug 2022 | $25M | $100M | Cercano Management · Global Health Investment Corporation · WRF Capital · Boom Capital Ventures | ↗ |
| SEED✓Equity / VC | Dec 2021 | $6M | $24M | Undisclosed | ↗ |
| SPINOUT✓Other financing | Jan 2021 | — | — | University of Washington · University of Washington Institute for Protein Design | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 28 |
| 2025 | 31 |
| 2024 | 29 |
| 2023 | 35 |
| 2022 | 26 |
Growth signals
Monod Bio website traffic
Latest recorded traffic for Monod Bio is 2.9K monthly website visits, down 19.4% over the last three months. Monod Bio's team declined 12.9% over the past year.
Comparisons
Monod Bio compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Monod Bio's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Monod Bio has talent and traffic
team presence
In the news
Latest news about Monod Bio
Recent press, funding announcements, and product moves mentioning Monod Bio — open to read from the original sources.
Market sentiment
What the market is saying about Monod Bio
An AI-synthesized read of the highest-engagement posts about Monod Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Monod Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.


















